Repligen RGEN
NASDAQ RGEN
$167.79 +1.27 (+0.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Repligen (RGEN) Share-based Compensation (IS) (2009 - 2011)

Updated

Analysis

Repligen (RGEN) Share-based Compensation (IS) (2009 - 2011) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn -
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn -
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn -
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn -
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn -
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn -
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn -
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn -
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn -
10 Repligen 9.51 Bn 6.29 Bn 110.99 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 175,176.00
Jun 30, 2011 194,625.00
Mar 31, 2011 183,252.00
Dec 31, 2010 181,003.00
Sep 30, 2010 177,957.00
Jun 30, 2010 186,940.00
Mar 31, 2010 175,975.00
Dec 31, 2009 230,751.00
Sep 30, 2009 175,672.00
Jun 30, 2009 174,124.00
Mar 31, 2009 179,721.00
API Access

Repligen Share-based Compensation (IS) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=RGEN&period=max&api_key=YOUR_API_KEY